These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23143982)

  • 1. Regulation of tumor dormancy and role of microenvironment: a mathematical model.
    Kim Y; Boushaba K
    Adv Exp Med Biol; 2013; 734():237-59. PubMed ID: 23143982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model for the regulation of tumor dormancy based on enzyme kinetics.
    Boushaba K; Levine HA; Nilsen-Hamilton M
    Bull Math Biol; 2006 Oct; 68(7):1495-526. PubMed ID: 16874553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
    Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
    Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multiscale Mathematical Model of Tumour Invasive Growth.
    Peng L; Trucu D; Lin P; Thompson A; Chaplain MA
    Bull Math Biol; 2017 Mar; 79(3):389-429. PubMed ID: 28210916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
    Hanin L
    Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activation by airway smooth muscle is regulated by type I collagen.
    Schuliga M; Harris T; Stewart AG
    Am J Respir Cell Mol Biol; 2011 Jun; 44(6):831-9. PubMed ID: 20693403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
    Korczak B; Kerbel RS; Dennis JW
    Cell Growth Differ; 1991 Jul; 2(7):335-41. PubMed ID: 1782152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution and morphology of microenvironment-enhanced malignancy of three-dimensional invasive solid tumors.
    Jiao Y; Torquato S
    Phys Rev E Stat Nonlin Soft Matter Phys; 2013 May; 87(5):052707. PubMed ID: 23767566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
    Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
    Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
    Choong PF; Nadesapillai AP
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.
    Waltz DA; Sailor LZ; Chapman HA
    J Clin Invest; 1993 Apr; 91(4):1541-52. PubMed ID: 8386190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I; Baley PA; Thompson TC
    Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.